Lexus to reveal CT 200h at the 2010 Geneva Motor Show

  • World premiere of the Lexus CT 200h
  • A fresh new gateway to progressive luxury and the Lexus brand
  • The first and only full hybrid vehicle in the premium compact segment

Six months after the LF-Ch concept was revealed, Lexus will unveil the new CT 200h at the 2010 Geneva Motor Show.

Created for those who wish to lower their emissions but not their standards, the CT 200h will be the first, and only, full hybrid vehicle in the premium compact segment. It will bring new levels of refinement, sophistication and attention to detail to the segment, without any compromise on style or driving pleasure.

Featuring second generation Lexus Hybrid Drive technology, the CT 200h reinforces Lexus' hybrid leadership in the premium market, joining the RX 450h, GS 450h and LS 600h to create an unprecedented range of full-hybrid vehicles.

The Lexus LFA will also be on show at Geneva, offering the opportunity to review the critically-acclaimed supercar in Europe before the initial order period closes at the end of the motor show.

Lexus' press conference will be conducted by Mr. Andy Pfeiffenberger, Vice President Lexus Europe, and is scheduled for 16.45 on 2nd March, on Stand 4211 in Hall 4.


About Lexus

Launched in 1989, Lexus has become renowned throughout the world for its pursuit of perfection, the outstanding quality and sophisticated high-technology content of its products, and for its unique concept of complete customer service. Further reinforcing the traditional Lexus values of unparalleled build quality, interior luxury and state-of-the-art technology, the L-finesse design philosophy represents a highly significant factor in positioning Lexus as a uniquely desirable global brand. Today, Lexus remains the first - and only - premium automotive manufacturer to offer a comprehensive full-hybrid model range comprising the RX 450h, the GS 450h, and the LS 600h. In Europe, the mix of Lexus Hybrid Drive is approximately 50% for the GS and the LS range, and around 80% for the RX.